FDA seeks Comments on Ways to Avoid Gluten in Drug Products
The Food and Drug Administration is seeking comments and information that will assist it in its deliberations about ways to help individuals with celiac disease avoid the presence of gluten in drug products. In particular, FDA is interested in information…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
on ingredients present in human drug products marketed in the U.S. that are currently derived from wheat, barley, or rye. Comments are due by February 21, 2012.